Pew, Drug Makers Urge Senators To Pass Antibiotic Incentives Package

By David Roza
February 6, 2019 at 4:50 PM
A group of drug makers and other health care stakeholders wrote to Senate health and Finance committee leaders on Tuesday (Feb. 5) asking them to pass a package of incentives to boost antibiotic development, saying pharmaceutical companies and investors are losing interest in the field due to a lack of return on new product development. The 13 signatories include The Pew Charitable Trusts, Pfizer, Inc., Infectious Diseases Society of America, Merck and the Antimicrobials Working Group, which includes 14 pharmaceutical...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.